Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,397
Out of 4,749 analysts
5
Total ratings
n/a
Success rate
-23.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $6.70 | +243.28% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $18.28 | +118.82% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $49.46 | +41.53% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $38.10 | +125.72% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $6.70
Upside: +243.28%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $18.28
Upside: +118.82%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $49.46
Upside: +41.53%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $38.10
Upside: +125.72%